Carriers heterozygous for the D124N (c.370, GAC > AAC in exon 4) variant of GCK not only exhibit reduced insulin-secretion, but also impaired adipose insulin sensitivity, which may shift fatty acids towards the liver. This could contribute to increased hepatic lipid-accumulation and alterations of liver energy metabolism resulting in dysglycemia. ClinicalTrial.gov registration no: NCT01055093.
Keywords: Beta-cell function; Glucokinase; Hepatic energy metabolism; Insulin sensitivity; MODY.
Copyright © 2022 Elsevier B.V. All rights reserved.